LungVax vaccine: World’s first lung cancer prevention Trial gets £2.06M funding — can we stop lung cancer before it starts?
A world-first clinical trial is about to test the LungVax vaccine, an experimental preventive vaccine designed to train the immune system to recognise and destroy early abnormal lung cells before they form tumours. This four-year Phase I trial has been awarded up to £2.06 million in funding and is led by researchers at University College … Read more
